Visx
This article was originally published in The Gray Sheet
Executive Summary
Financier Carl Icahn declares intent to nominate Keith Meister to the ophthalmic firm's board of directors. Icahn, who owns 11.6% of the company, had scrapped plans to elect a rival slate of directors in March. A hostile takeover was initially proposed in April 2001 (1"The Gray Sheet" Nov. 26, 2001, p. 30)...